SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (5423)9/28/1998 1:11:00 AM
From: scaram(o)uche  Read Replies (1) of 6136
 
88% versus 59%.

Quite a gap.

So, it's now official. It's been apparent for some time, but now it's official. While PIs may have their problems, there's nelf and.......... what is it that comes second?? Crix, 3X daily? Rit capsules? Saq?

Abbott, Merck and Glaxo..... I've been saying, in public and very loudly since Spring '95, that Agouron was going to polish your butts. Given this, I'm allowed the following commentary..... Merck, you did well.... you saved lives and your scientists made heroic efforts to make a dent in this disease. You came up with a molecule that didn't quite cut it, but there are many patients alive today that serve as a tribute to your efforts. Abbott..... you didn't get your butt polished, you got it blown away. What a "tail between your legs" effort! It wouldn't be too bad except for the bravado that you used to capture your piddly market share. Glaxo...... you look really foolish. "Second generation" my ass.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext